Page last updated: 2024-11-01

nicardipine and Diabetic Ketoacidosis

nicardipine has been researched along with Diabetic Ketoacidosis in 1 studies

Nicardipine: A potent calcium channel blockader with marked vasodilator action. It has antihypertensive properties and is effective in the treatment of angina and coronary spasms without showing cardiodepressant effects. It has also been used in the treatment of asthma and enhances the action of specific antineoplastic agents.
nicardipine : A racemate comprising equimolar amounts of (R)- and (S)-nicardipine. It is a calcium channel blocker which is used to treat hypertension.
2-[benzyl(methyl)amino]ethyl methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate : A dihydropyridine that is 1,4-dihydropyridine substituted by a methyl, {2-[benzyl(methyl)amino]ethoxy}carbonyl, 3-nitrophenyl, methoxycarbonyl and methyl groups at positions 2, 3, 4, 5 and 6, respectively.

Diabetic Ketoacidosis: A life-threatening complication of diabetes mellitus, primarily of TYPE 1 DIABETES MELLITUS with severe INSULIN deficiency and extreme HYPERGLYCEMIA. It is characterized by KETOSIS; DEHYDRATION; and depressed consciousness leading to COMA.

Research Excerpts

ExcerptRelevanceReference
"Infection and sepsis has been reported as a possible cause for this disorder."1.48A case of posterior reversible encephalopathy syndrome associated with sepsis. ( Garner, O; Iardino, A; Ramirez, A, 2018)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Garner, O1
Ramirez, A1
Iardino, A1

Other Studies

1 other study available for nicardipine and Diabetic Ketoacidosis

ArticleYear
A case of posterior reversible encephalopathy syndrome associated with sepsis.
    BMJ case reports, 2018, Jul-10, Volume: 2018

    Topics: Anticonvulsants; Antihypertensive Agents; Brain; Diabetic Ketoacidosis; Humans; Hypertension; Leveti

2018